Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

Share Price is delayed by 15 minutes
Get Live Data
39.50    3.00 (8.00%)
Bid:
38.00
Ask:
41.00
Spread: 3.00 (7.895%)
Market Cap: £17.74m
MANO Live PriceLast checked at - London Stock Exchange

Intraday Manolete Partn. Share Chart

Directors Dealing and TVR

Today 17:23

RNS Number : 4695K
Manolete Partners PLC
30 June 2026
 

30 June 2026

 

 

Manolete Partners PLC

("Manolete" or the "Company")

 

Directors Dealing and TVR

 

Manolete, the leading UK-listed insolvency litigation financing company, announces that Mena Halton, its Chief Executive Officer, yesterday exercised options over 175,000 ordinary shares of 0.4p each in the capital of the Company ("Ordinary Shares"). In order to satisfy the tax arising on exercise, the exercise price and the associated trading commissions she has today sold 108,305 Ordinary Shares at a price of 38p and will retain the balance of 66,695 Ordinary Shares. As a result of the transaction Mena Halton is now interested in 627,939 Ordinary Shares representing 1.43 per cent of the Company's issued share capital.

 

Application has been made for the 175,000 Ordinary Shares to be admitted to trading on AIM and it is expected that trading in them will commence on 6 July 2026.

Following this issue of Ordinary Shares the Company will have 43,985,966 Ordinary Shares in issue. The Company does not hold any Ordinary Shares in Treasury. This figure of 43,985,966 Ordinary Shares may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Company or its Group under the FCA's Disclosure Guidance and Transparency Rules.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Philomena Halton

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Manolete Partners plc

b)

LEI

213800R2X9V3KWCC4H47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.4p

Identification code

GB00BYWQCY12

b)

Nature of the transaction

Exercise of options over ordinary shares with an exercise price per ordinary share equal to the nominal value of an ordinary share

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.4p

175,000

d)

Aggregated information:

·Aggregated volume

·Price

Aggregated price

Aggregated volume

£700

175,000

e)

Date of the transaction

29 June 2026

 

f)

Place of the transaction

Outside of a trading venue 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Philomena Halton

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Manolete Partners plc

b)

LEI

213800R2X9V3KWCC4H47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.4p

Identification code

GB00BYWQCY12

b)

Nature of the transaction

Sale of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

38p

108,305

d)

Aggregated information:

·Aggregated volume

·Price

Aggregated price

Aggregated volume

£41,155.90

108,305

e)

Date of the transaction

30 June 2026

 

f)

Place of the transaction

London Stock Exchange

 

 

 

For further information please contact:

 

Manolete Partners

Mena Halton (Chief Executive Officer) via Houston

Will Sawyer (Chief Financial Officer)

 

Canaccord (NOMAD and Sole Broker) +44 (0)20 7523 8000

Emma Gabriel

Stuart Andrews

Harry Rees

 

Houston (Financial PR) +44 (0)77 3303 2695

Charlie Barker +44 (0)20 4529 0549

Nick Jackman

Manolete@houston.co.uk

 

About Manolete Partners PLC

Manolete Partners Plc is the UK's leading insolvency claims financing company. Serving a growing market worth over £500 million annually, the Company has a highly experienced team with coverage across the UK and a proven track record of generating strong historic returns across over 1,400 cases financed and completed to date.

 

Widely recognised as the industry leader, Manolete is the only company in the insolvency litigation funding section to be ranked in Band 1 of the legal industry's prestigious Chambers Guide five times. The Company is also five-time winner of 'Insolvency Litigation Funder of the Year' at the Turnaround, Restructuring and Insolvency Industry Awards.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKKBBABKDBAN
Date   Source Headline
30th Jun 20265:23 pmRNSDirectors Dealing and TVR
26th Jun 20267:00 amRNS-RManolete ranked in Band 1 by Chambers for 6th year
26th Jun 20267:00 amRNSPosting of Annual Report and Notice of AGM
25th Jun 20267:00 amRNSFull Year Results
19th Jun 20267:00 amRNSNotice of FY26 Results and Investor Presentation
1st Jun 20267:00 amRNSBlock Listing Six Monthly Return
20th May 202612:00 pmRNSDirectorate Change
28th Apr 20263:19 pmRNSHolding(s) in Company
24th Apr 20267:00 amRNSFull Year Trading Update
31st Mar 20267:00 amRNSDirectorate Changes
22nd Dec 20257:00 amRNSGrant of Share Options
22nd Dec 20257:00 amRNSGrant of Share Options
17th Dec 20253:13 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSBlock Listing Six Monthly Return
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20254:10 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSHalf-year results
4th Nov 20257:00 amRNSNotice of Interim Results
16th Sep 20252:41 pmRNSResult of AGM
16th Sep 20257:00 amRNSAGM Update
22nd Aug 20257:00 amRNSDirectorate Change
20th Aug 202512:11 pmRNSPosting of Annual Report and Notice of AGM
11th Aug 20257:00 amRNSBoard Changes
5th Aug 202510:18 amRNSHolding(s) in Company
5th Aug 202510:17 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
28th Jul 20258:30 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSTruck Cartel Case Settlement
14th Jul 20257:00 amRNS-RMelloMonday Investor Webinar
9th Jul 20251:45 pmRNSHolding(s) in Company
26th Jun 20257:00 amRNSFull Year Results
25th Jun 20257:00 amRNS-RManolete ranked in Band 1 by Chambers
19th Jun 20252:45 pmRNSHolding(s) in Company
19th Jun 20251:54 pmRNSNotice of Results
30th May 20257:00 amRNSBlock Listing Six Monthly Return
29th Apr 20257:00 amRNSTrading Update
7th Apr 202512:41 pmRNSDirectorate Change
28th Mar 20257:00 amRNSNew Revolving Credit Facility with HSBC Bank
4th Feb 20257:00 amRNSUpdate on Cartel Claims
29th Nov 20247:00 amRNSBlock Listing Six Monthly Return
19th Nov 20247:00 amRNSHalf-year Report
24th Oct 20241:49 pmRNSNotice of Results
17th Oct 202412:35 pmRNSDirector/PDMR Shareholding
30th Sep 202411:49 amRNSResult of AGM
20th Sep 20247:00 amRNSGrant of Share Options
6th Sep 20241:41 pmRNSPosting of Annual Report and Notice of AGM
3rd Sep 20247:00 amRNSAudited results for the year ended 31 March 2024
29th Aug 20247:00 amRNSRetail Investor Presentation
25th Jul 20245:09 pmRNSPCA Shareholding
27th Jun 20247:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.